Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

MapLight Therapeutics, Inc.

NASDAQ: MPLT · Life Sciences · 10 alerts · CIK 1770069

Share price
$6.90Close, Nov 16
Market cap
$293M
Shares outstanding
42.44MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All MapLight Therapeutics, Inc. filings on SEC EDGAR ↗

5:00 PM ET Form 4
Insider Selling

MapLight Therapeutics Chief Discovery Officer Anatol Kreitzer Sells $96K of Stock

Anatol Kreitzer, Chief Discovery Officer, sold 12,248 shares of MapLight Therapeutics, Inc. at $7.84 a share, worth $96K in total on Oct 15, 2026. Shares held after the trade: 168,678 (-6.8%).

Value
$96K
Shares
12,248
Price
$7.84
Role
Chief Discovery Officer
Holding change
-6.8%
Trade date
Oct 15, 2026
5:00 PM ET Form 4
Insider Selling

MapLight Therapeutics CMO Erin Pennock Foff Sells $124K of Stock

Erin Pennock Foff, CMO, sold 15,355 shares of MapLight Therapeutics, Inc. at $8.08 a share, worth $124K in total on Oct 15, 2026. Shares held after the trade: 296,906 (-4.9%).

Value
$124K
Shares
15,355
Price
$8.08
Role
CMO
Holding change
-4.9%
Trade date
Oct 15, 2026
5:00 PM ET Form 4
Insider Selling

MapLight Therapeutics General Counsel Kristopher Hanson Sells $72.9K of Stock

Kristopher Hanson, General Counsel, sold 9,020 shares of MapLight Therapeutics, Inc. at $8.08 a share, worth $72.9K in total on Oct 15, 2026. Shares held after the trade: 128,024 (-6.6%).

Value
$72.9K
Shares
9,020
Price
$8.08
Role
General Counsel
Holding change
-6.6%
Trade date
Oct 15, 2026
5:00 PM ET Form 4
Insider Selling

MapLight Therapeutics CAO and Interim CFO Jonathan Gillis Sells $82.1K of Stock

Jonathan Gillis, CAO and Interim CFO, sold 10,167 shares of MapLight Therapeutics, Inc. at $8.08 a share, worth $82.1K in total on Oct 15, 2026. Shares held after the trade: 142,315 (-6.7%).

Value
$82.1K
Shares
10,167
Price
$8.08
Role
CAO and Interim CFO
Holding change
-6.7%
Trade date
Oct 15, 2026
5:00 PM ET Form 4
Insider Selling

MapLight Therapeutics CSO James Woodruff Lillie Sells $93K of Stock

James Woodruff Lillie, CSO, sold 11,513 shares of MapLight Therapeutics, Inc. at $8.08 a share, worth $93K in total on Oct 15, 2026. Shares held after the trade: 198,597 (-5.5%).

Value
$93K
Shares
11,513
Price
$8.08
Role
CSO
Holding change
-5.5%
Trade date
Oct 15, 2026
5:00 PM ET Form 4
Insider Selling

MapLight Therapeutics CEO Christopher A. Kroeger Sells $595K of Stock

Christopher A. Kroeger, CEO, sold 73,691 shares of MapLight Therapeutics, Inc. at $8.08 a share, worth $595K in total on Oct 15, 2026. Shares held after the trade: 1,195,909 (-5.8%).

Value
$595K
Shares
73,691
Price
$8.08
Role
CEO
Holding change
-5.8%
Trade date
Oct 15, 2026
4:15 PM ET Form 4
Insider Selling

MapLight Therapeutics General Counsel Kristopher Hanson Sells $193K of Stock

Kristopher Hanson, General Counsel, sold 16,509 shares of MapLight Therapeutics, Inc. at $11.67 a share, worth $193K in total on Sep 16, 2026. Shares held after the trade: 137,044 (-10.8%).

Value
$193K
Shares
16,509
Price
$11.67
Role
General Counsel
Holding change
-10.8%
Trade date
Sep 16, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.